Adamis Pharmaceuticals Corporation Issues Nationwide
SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) is voluntarily recalling certain lots of SYMJEPI...
Stay updated with breaking news from Admp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) is voluntarily recalling certain lots of SYMJEPI...
DSMB met to evaluate interim clinical and safety data and clears Phase 2/3 study to continue...
Adamis Pharmaceuticals Co. (NASDAQ:ADMP – Get Rating)’s share price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.84 and traded as low as $0.59. Adamis Pharmaceuticals shares last traded at $0.60, with a volume of 1,140,265 shares trading hands. A […]
ArisGlobal's industry-leading regulatory software chosen by top pharmaceutical company for IDMP preparation and global readiness MIAMI, Feb. 16, 2022 /PRNewswire/ -- ArisGlobal, the leading
• A seasoned regulated data & content management specialist Bart has joined Generis from Morae Global where he was Senior Commercial Director for EMEA ...